Article Details

4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer

Retrieved on: 2021-06-07 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer. View article details on hiswai:

Excerpt

... external innovation, pre-commercial planning, product pipeline strategy and venture investing brings valuable skillsets to 4DMT,” said David Kirn, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up